UNSPSC 85771862: Alteration of right upper extremity with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to alteration of right upper extremity with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0X060KZ

UNSPSC 85771862 Alteration of right upper extremity with nonautologous tissue substitute, open approach (Commodity) does not align with the scope of work actually being solicited by state and local governments in recent opportunities. The code's nominal title references a specific surgical procedure, yet the recent state and local contract opportunities tagged under this code involve occupational medical surveillance, independent disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical benefit carve-outs, and emergency medical services for detained youth—none of which describe upper extremity alteration with tissue substitutes. This mismatch suggests the code has been applied incorrectly to health services administration and occupational health contracting rather than to the orthopedic surgical procedures its name implies.

The recent opportunities under this code span diverse issuing bodies including county health departments and human resources divisions (Santa Clara County Health System, Collier County), city retirement boards (City of Phoenix), state transportation departments (Washington State Department of Transportation), municipal governments (City of Long Beach), and county juvenile justice agencies (Harris County). Geographic activity centers on Arizona, California, Florida, and Washington, with only one sourced opportunity from a single state agency. No clear repeat buyers or concentrated market pattern emerges from the available sample. Without opportunities that genuinely reflect the commodity's stated scope—surgical procedures involving nonautologous tissue grafting to the upper extremity—the code shows little decision-relevant activity for firms pursuing orthopedic surgical procurement.